Mohamed Abou‐El‐Enein

University of Southern California — United States

Medicine · Health Sciences

26h-index2.9kcitations73works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(42), Biomedical Ethics and Regulation(19), Virus-based gene therapy research(13), Viral Infectious Diseases and Gene Expression in Insects(13), CRISPR and Genetic Engineering(12)

Publications72 total

Some New Convergence Approaches in Banach Spaces Involving the HK-Iteration Method with Application
Contemporary Mathematics·2025Open Access
Molecular Therapy Advances: Building the bridge between discovery and cure
Molecular Therapy — Methods & Clinical Development·2025Open Access
Revisiting the environmental resource curse in MENA: Do export diversification and renewable energy matter?
Journal of Environmental Management·2025· 2 cited
A clinical roadmap for base and prime editing
Nature Reviews Bioengineering·2025· 3 cited
A Novel U-Statistic Test for Exponentiality Against EBUCL Reliability Class and Applied to Complete and Censored Data Across Various Risk Profiles
European Journal of Pure and Applied Mathematics·2025Open Access
Key factors in environmental quality: Green finance, energy and trade
Energy Strategy Reviews·2025· 7 citedOpen Access
High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing
Molecular Therapy·2025· 25 citedOpen Access
Redefining quality in cell and gene therapies: Lessons from implementing electronic QMS in academic cGMP facility
Molecular Therapy·2025· 4 citedOpen Access
Advancing cell therapy manufacturing through precision genome engineering
Elsevier eBooks·2025
Copula-based analysis of asymmetrically distributed joint data under a risk profile using the discrete Type-I extreme value distribution
Electronic Research Archive·2025· 1 citedOpen Access
Inference on stress-strength reliability from censored data using the asymmetric generalized Poisson Lomax model
AIMS Mathematics·2025Open Access
P238 Intravesical treatment in patients with high risk non-muscle invasive bladder cancercan treatment with sequential bacillus calmette-guérin/electromotive drug administration of mitomycin c delay or even prevent it?
European Urology Open Science·2024Open Access
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
UNC Libraries·2024Open Access
Biomanufacturing in gene and cell therapy
Molecular Therapy — Methods & Clinical Development·2024· 3 citedOpen Access
The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy
Blood Cancer Discovery·2024· 33 citedOpen Access
Disseminating transformative gene and cell therapy research
Molecular Therapy — Methods & Clinical Development·2024Open Access
Integration of <i>ζ</i>-deficient CARs into the <i>CD3</i> <i>ζ</i> gene conveys potent cytotoxicity in T and NK cells
Blood·2024· 36 citedOpen Access
Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma
Blood Advances·2023· 16 citedOpen Access
Integration of ζ-deficient CARs into the <i>CD3-zeta</i> gene conveys potent cytotoxicity in T and NK cells
2023· 5 citedOpen Access
Bringing base editing to the clinic: The next generation of genome editors
Molecular Therapy — Methods & Clinical Development·2023· 3 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Petra Reinke(14), Gerhard Bauer(10), Magdi Elsallab(9), Hans‐Dieter Volk(9), Dimitrios L. Wagner(6), Michael Schmueck‐Henneresse(5), Christian Flugel(4), Enrico Fritsche(4), Ulrik Stervbo(4), Nina Babel(4), Amaia Cadiñanos-Garai(4), Toni Cathomen(4), Daniel R. Kaiser(3), Ahmed Elsanhoury(3), Hisham Abdel‐Azim(3), Jonas Kath(3), Clemens Franke(3), Vanessa Drosdek(3), Weijie Du(3), Viktor Glaser(3)